Lebedyeva Iryna O, Ostrov David A, Neubert John, Steel Peter J, Patel Kunal, Sileno Sean M, Goncalves Kevin, Ibrahim Mohamed A, Alamry Khalid A, Katritzky Alan R
Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, USA.
Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32611, USA.
Bioorg Med Chem. 2014 Feb 15;22(4):1479-86. doi: 10.1016/j.bmc.2013.12.017. Epub 2013 Dec 12.
Synthetic approaches to gabapentin bioconjugates that overcome the tendency of gabapentin to cyclize into its γ-lactam are studied. Gabapentin was converted by N-acylation at its N-terminus into di-, tri-, and tetrapeptides (L-Ala-Gbp, L-Val-Gbp, L-Ala-L-Phe-Gbp, Gly-L-Ala-β-Ala-Gbp). Carboxyl-activated Boc-protected gabapentin was used to N-, O-, and S-acylate small peptides and hormones to give conjugates that could also provide prodrugs containing conformationally constrained gabapentin units.
研究了克服加巴喷丁环化形成其γ-内酰胺倾向的加巴喷丁生物共轭物的合成方法。加巴喷丁通过其N端的N-酰化反应转化为二肽、三肽和四肽(L-丙氨酸-加巴喷丁、L-缬氨酸-加巴喷丁、L-丙氨酸-L-苯丙氨酸-加巴喷丁、甘氨酸-L-丙氨酸-β-丙氨酸-加巴喷丁)。羧基活化的Boc保护的加巴喷丁用于对小肽和激素进行N-、O-和S-酰化反应,以得到共轭物,这些共轭物也可以提供含有构象受限加巴喷丁单元的前药。